Hired and retired: New appointments in the biopharma industry
Pfizer, Merck and Moderna are among the companies making changes in top-level jobs this month.
Archives for April 20, 2022
Arcturus’ self-amplifying COVID-19 mRNA vaccine meets Phase 3 primary efficacy endpoint
Arcturus Therapeutics Holdings Inc. has reported topline data from an ongoing Phase 1/2/3 trial evaluating ARCT-154, its self-amplifying mRNA COVID-19 vaccine candidate.
Finch Therapeutics to shed 20% of its workforce
Following the announcement of layoffs at several biotech firms in recent weeks, a restructuring program is also underway at Finch Therapeutics.
Biocytogen and CtM Bio look to enhance immunotherapy by turning cold tumors hot
Chinese companies, Biocytogen Pharmaceuticals and CtM Biotech Co Ltd, are collaborating on the development of antibody drugs against intracellular tumor-associated antigens.